These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 580441)

  • 1. Comparison of the antitumor activity and toxicity of 2,4-diamino-5-(1-adamantyl)-6-methylpyrimidine and 2,4-diamino-5-(1-adamantyl)-6-ethylpyrimidine.
    Zakrzewski SF; Dave C; Rosen F
    J Natl Cancer Inst; 1978 May; 60(5):1029-33. PubMed ID: 580441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies with a new antifolate 2,4-diamino-5-adamantyl-6-methylpyrimidine (DAMP): tissue distribution and disposition of 2,4-diamino-5-adamantyl-6-methylpyrimidine and its metabolite.
    Zakrzewski SF; Dave C; Mead LH; Deluomo DS
    J Pharmacol Exp Ther; 1978 Apr; 205(1):19-26. PubMed ID: 633083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of antitumor activity of 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine and Baker's antifol (triazinate) with carboxypeptidase G1.
    Kalghatgi KK; Moroson BA; Horváth C; Bertino JR
    Cancer Res; 1979 Sep; 39(9):3441-5. PubMed ID: 476673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity and pharmacokinetics of a new antifolate, 2,4-diamino-5-adamantyl-6-methylpyrimidine, in dogs.
    Zakrzewski SF; Pavelic Z; Greco WR; Bullard G; Creaven PJ; Mihich E
    Cancer Res; 1982 Jun; 42(6):2177-83. PubMed ID: 7074598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition by hydrazine sulfate and various hydrazides, of in vivo growth of Walker 256 intramuscular carcinoma, B-16 melanoma, Murphy-Sturm lymphosarcoma and L-1210 solid leukemia.
    Gold J
    Oncology; 1973; 27(1):69-80. PubMed ID: 4739164
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular structures of 2,4-diaminopyrimidine antifolates with antineoplastic activity.
    Cody V; Zakrzewski SF
    J Med Chem; 1982 Apr; 25(4):427-30. PubMed ID: 7069721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonclassical 2,4-diamino-5-aryl-6-ethylpyrimidine antifolates: activity as inhibitors of dihydrofolate reductase from Pneumocystis carinii and Toxoplasma gondii and as antitumor agents.
    Robson C; Meek MA; Grunwaldt JD; Lambert PA; Queener SF; Schmidt D; Griffin RJ
    J Med Chem; 1997 Sep; 40(19):3040-8. PubMed ID: 9301666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antitumor activity of 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methylpyrido[2,3-d]pyrimidine.
    Grivsky EM; Lee S; Sigel CW; Duch DS; Nichol CA
    J Med Chem; 1980 Mar; 23(3):327-9. PubMed ID: 6928967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies with a 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (DDMP)-resistant L1210 leukemia cell line without cross-resistance to methotrexate.
    Browman GP; Gorka C; Mehta C; Lazarus H; Abelson HT
    Biochem Pharmacol; 1980 Aug; 29(16):2241-5. PubMed ID: 7426028
    [No Abstract]   [Full Text] [Related]  

  • 10. 6-substituted 2,4-diamino-5-(4-carbethoxyphenylazo)pyrimidines as potential precursors of tetrahydropteridine antimetabolites.
    Chadwick M; Hampshire J; Hebborn P; Triggle AM; Triggle DJ
    J Med Chem; 1966 Nov; 9(6):874-6. PubMed ID: 6013234
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antitumor activity of prospidin].
    Sorkina IuA; Chernov VA; Grushina AA; Khramchenkova SP
    Vopr Onkol; 1970; 16(7):83-6. PubMed ID: 5274101
    [No Abstract]   [Full Text] [Related]  

  • 12. Crystallographic studies of the antineoplastic antifolate 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (DDMP) ethanesulfonate salt.
    Cody V
    Cancer Biochem Biophys; 1983; 6(3):173-7. PubMed ID: 6850552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 1, 3-diallylurea and related compounds on growth of transplanted animal tumors.
    Tarnowski GS; Cappuccino JG; Schmid FA
    Cancer Res; 1967 Jun; 27(6):1092-5. PubMed ID: 5229785
    [No Abstract]   [Full Text] [Related]  

  • 14. Biological activity of bacterial lectins and their molecular complexes with heterocyclic bis-adducts.
    Welchinskaya HV; Piecuszak B; Kovalenko EA; Sharykina NI; Getman KI; Podgorsky VS
    Mikrobiol Z; 2003; 65(5):20-5. PubMed ID: 14723158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor and toxicologic effects of p-carboxycarbanilic acid, N-(p-(bis(2-chloroethyl)amino)phenyl) ester (NSC-130998; IC 140).
    Hebborn P; Simpson CL; Mihich E
    Cancer Chemother Rep; 1970 Feb; 54(1):23-30. PubMed ID: 5538162
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental chemotherapy with 5-arylpyrimidine antifolates: Further studies on toxicity and the responsiveness of ascitic, solid, and intracranial sarcoma 180 to DDMP and DDMP with citrovorum factor.
    Sirotnak FM; Moccio DM; Dorick DM
    Cancer Treat Rep; 1977 Oct; 61(7):1325-32. PubMed ID: 303937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effects of methylglyoxal-bis(N-4-methylthiosemicarbazone) and their potentiation in pyridoxine-deficient animals.
    Mihich E; Nichol CA
    Cancer Res; 1965 Jul; 25(6):794-801. PubMed ID: 5214034
    [No Abstract]   [Full Text] [Related]  

  • 18. Sex-linked inhibition of tumors by pyruvaldehyde Bis(thiosemicarbazone).
    Cappuccino JG; Mountain IM; Tarnowski GS; Balis ME
    Cancer Res; 1967 Feb; 27(2):377-84. PubMed ID: 6071245
    [No Abstract]   [Full Text] [Related]  

  • 19. DDMP (2,4-diamino-5-(3',4'-dichlorophenyl)-methylpyrimidine).
    Hill BT; Price LA
    Cancer Treat Rev; 1980 Jun; 7(2):95-112. PubMed ID: 6996812
    [No Abstract]   [Full Text] [Related]  

  • 20. Activity of 10-chloro-5-(2-dimethylaminoethyl)-7H-indolo [2,3-c]-quinolin-6(5H)-one hydrochloride against experimental tumors in mice and rats.
    Grunberg E; Kramer MJ; Buck M; Trown PW
    Chemotherapy; 1978; 24(2):77-80. PubMed ID: 579626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.